Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy [5]

New England Journal of Medicine

Volumn 343, Issue 6, 2000, Pages 445-446

  Berkovitch, Matitiahu ^a   Elbirt, Daniel ^a   Addis, Antony ^b   Schuler Faccini, Lavinia ^c   Ornoy, Asher ^d  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE; THALIDOMIDE;

ADULT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FETUS MALFORMATION; HUMAN; LETTER; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NAUSEA; PREGNANCY TERMINATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; VOMITING;

ABNORMALITIES; ABORTION, SPONTANEOUS; ANTIEMETICS; CASE-CONTROL STUDIES; FEMALE; FETUS; HUMANS; METOCLOPRAMIDE; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0034632820     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200008103430616     Document Type: Letter

References (5)

1. Nausea and vomiting of early pregnancy and pregnancy outcome: A meta-analytical review
2. Nausea and vomiting in pregnancy: A review of the problem with particular regard to psychological and social aspects
3. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester
4. Nausea and vomiting in pregnancy: A comparative European study